{{Drugbox
| Verifiedfields = 
| Watchedfields = 
| verifiedrevid = 
| IUPAC_name = (3S,8R,9S,10R,13S,14S,17S)-13-methyl-1,2,3,6,7,8,9,10,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthrene-3,17-diol
| image = Bolandiol.svg
| width = 250

<!--Clinical data-->
| tradename = 
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category = 
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = 
| legal_UK = 
| legal_US = 
| legal_status = 
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability = 
| protein_bound = 
| metabolism = 
| elimination_half-life = 
| excretion =

<!--Identifiers-->
| CAS_number_Ref = 
| CAS_number = 19793-20-5
| CAS_supplemental = 
| ATC_prefix = 
| ATC_suffix = 
| PubChem = 9835303
| DrugBank_Ref = 
| DrugBank = 
| ChemSpiderID_Ref = 
| ChemSpiderID = 8011024
| UNII = 
| ChEMBL = 2106664

<!--Chemical data-->
| C=18 | H=28 | O=2
| molecular_weight = 
| smiles = O[C@@H]4/C=C2\[C@@H]([C@H]1CC[C@@]3([C@@H](O)CC[C@H]3[C@@H]1CC2)C)CC4
| StdInChI_Ref = 
| StdInChI = 1S/C18H28O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h10,12-17,19-20H,2-9H2,1H3/t12-,13-,14+,15+,16-,17-,18-/m0/s1
| StdInChIKey_Ref = 
| StdInChIKey = CMXKUJNZWYTFJN-XFUVECHXSA-N
| synonyms = 19-Norandrostenediol; 19-Nor-4-androstene-3β,17β-diol; Estr-4-ene-3β,17β-diol; 3β-Dihydronandrolone
}}

'''Bolandiol''' ([[International Nonproprietary Name|INN]]), also known as '''19-nor-4-androstenediol''', '''estr-4-en-3β,17β-diol''', or '''3β-dihydronandrolone''', is an [[anabolic-androgenic steroid]] (AAS) that was never marketed.<ref name="Elks2014">{{cite book|author=J. Elks|title=The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies|url=https://books.google.com/books?id=0vXTBwAAQBAJ&pg=PA899|date=14 November 2014|publisher=Springer|isbn=978-1-4757-2085-3|pages=899–}}</ref> A [[dipropionate]] [[ester]], [[bolandiol dipropionate]] (brand names '''Anabiol''', '''Storinal'''; former developmental code name '''SC-7525'''), has been marketed.<ref name="Elks2014" /><ref name="HydeGengenbach2007">{{cite book|author1=Thomas E. Hyde|author2=Marianne S. Gengenbach|title=Conservative Management of Sports Injuries|url=https://books.google.com/books?id=uzPwfNYyjjUC&pg=PA1100|year=2007|publisher=Jones & Bartlett Learning|isbn=978-0-7637-3252-3|pages=1100–}}</ref> Bolandiol (and its dipropionate ester) is unique among AAS in that it reportedly also possesses [[estrogen]]ic and [[progestogen]]ic activity.<ref>{{cite book|title=Hormones: Advances in Research and Application: 2011 Edition|url=https://books.google.com/books?id=zhzrlLrsI4AC&pg=PT59|date=9 January 2012|publisher=ScholarlyEditions|isbn=978-1-4649-2242-8|pages=59–}}</ref><ref>{{Cite journal |pmid = 19941958 |year = 2010 |last1 = Attardi |first1 = BJ |last2 = Page |first2 = ST |last3 = Hild |first3 = SA |last4 = Coss |first4 = CC |last5 = Matsumoto |first5 = AM |title = Mechanism of action of bolandiol (19-nortestosterone-3beta,17beta-diol), a unique anabolic steroid with androgenic, estrogenic, and progestational activities |volume = 118 |issue = 3 |pages = 151–61 |doi = 10.1016/j.jsbmb.2009.11.008 |pmc = 2831543 |journal = The Journal of Steroid Biochemistry and Molecular Biology}}</ref>

Bolandiol is on the [[World Anti-Doping Agency]]'s list of prohibited substances,<ref>{{cite web | url=http://www.wada-ama.org/Documents/World_Anti-Doping_Program/WADP-Prohibited-list/2012/WADA_Prohibited_List_2012_EN.pdf | title=The World Anti-Doping Code: The 2012 Prohibited List | publisher=[[World Anti-Doping Agency]] | accessdate=2012-07-17 | deadurl=yes | archiveurl=https://web.archive.org/web/20120513020202/http://www.wada-ama.org/Documents/World_Anti-Doping_Program/WADP-Prohibited-list/2012/WADA_Prohibited_List_2012_EN.pdf | archivedate=2012-05-13 | df= }}</ref> and is therefore banned from use in most major sports.  It is a potential [[metabolism|metabolic]] precursor to [[nandrolone]].<ref>{{Cite journal | title = Human nutritional supplements in the horse: comparative effects of 19-norandrostenedione and 19-norandrostenediol on the 19-norsteroid profile and consequences for doping control |author1=Dehennin, L. |author2=Bonnaire, Y. |author3=Plou, Ph. | journal = Journal of Chromatography B  | year = 2002 | volume = 766 | issue = 2 | pages = 257–263 | doi = 10.1016/S0378-4347(01)00506-0}}</ref> However, several clinical studies have concluded that bolandiol does not alter strength, body composition, or exercise performance.<ref>{{Cite journal |pmid = 11417430 |year = 2001 |last1 = Van Gammeren |first1 = D |last2 = Falk |first2 = D |last3 = Antonio |first3 = J |title = The effects of supplementation with 19-nor-4-androstene-3,17-dione and 19-nor-4-androstene-3,17-diol on body composition and athletic performance in previously weight-trained male athletes |volume = 84 |issue = 5 |pages = 426–31 |journal = European journal of applied physiology |doi=10.1007/s004210100395}}</ref><ref>{{Cite journal |pmid = 12297208 |year = 2002 |last1 = Van Gammeren |first1 = D |last2 = Falk |first2 = D |last3 = Antonio |first3 = J |title = Effects of norandrostenedione and norandrostenediol in resistance-trained men |volume = 18 |issue = 9 |pages = 734–7 |journal = Nutrition |doi=10.1016/s0899-9007(02)00834-1}}</ref>

==See also==
* [[4-Androstenediol]]
* [[19-Nor-5-androstenediol]]
* [[19-Nor-5-androstenedione]]
* [[Bolandione]] (19-nor-4-androstenedione)
* [[Bolenol]] (17α-ethyl-19-nor-5-androstenol)

==References==
{{reflist|30em}}

{{Androgens and antiandrogens}}
{{Androgen receptor modulators}}
{{Estrogen receptor modulators}}
{{Progesterone receptor modulators}}

[[Category:Androgens and anabolic steroids]]
[[Category:Estranes]]
[[Category:Estrogens]]
[[Category:Progestogens]]
[[Category:World Anti-Doping Agency prohibited substances]]